Cargando…
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival
IMPORTANCE: There exists considerable biological and clinical variability between histologic variants of metastatic renal cell carcinoma (mRCC). Data reporting on patterns of metastasis in histologic variants of mRCC are sparse. OBJECTIVE: To characterize sites of metastasis and their association wi...
Autores principales: | Dudani, Shaan, de Velasco, Guillermo, Wells, J. Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Lee, Jae Lyun, Hansen, Aaron, Bjarnason, Georg A., Beuselinck, Benoit, Pal, Sumanta K., Yuasa, Takeshi, Kroeger, Nils, Kanesvaran, Ravindran, Reaume, M. Neil, Canil, Christina, Choueiri, Toni K., Heng, Daniel Y. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821027/ https://www.ncbi.nlm.nih.gov/pubmed/33475752 http://dx.doi.org/10.1001/jamanetworkopen.2020.21869 |
Ejemplares similares
-
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
por: Yip, Steven M., et al.
Publicado: (2017) -
Characterizing the outcomes of metastatic papillary renal cell carcinoma
por: Connor Wells, John, et al.
Publicado: (2017) -
Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
por: Gan, Chun Loo, et al.
Publicado: (2021) -
Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC
por: Lin, Tsu-Feng, et al.
Publicado: (2019) -
Relating Prognosis in Chromophobe Renal Cell Carcinoma to the Chromophobe Tumor Grading System
por: Weinzierl, Elizabeth P, et al.
Publicado: (2014)